Advertisement

Pacemaker and Internal Cardioverter-Defibrillator Therapies

  • J. L. Atlee
Part of the Topics in Anaesthesia and Critical Care book series (TIACC)

Abstract

Cardiac rhythm management devices (CRMD) have evolved significantly since the late 1950s, when the first pacemakers (PM) were implanted [1]. However, transcutaneous electrical cardiac stimulation was used to treat symptomatic advanced second-degree or third-degree atrioventricular (AV) heart block (Stokes-Adams attacks) in the 1920s [1, 2]. The first implantable devices were asynchronous ventricular PM (VOO1) for patients with Stokes-Adams attacks, and then evolved into dual-chamber PMs (DDD) to preserve AV synchrony [1, 2, 3, 4].2 Next, intracardiac sensing was added to avoid competition between paced and intrinsic rhythms in patients with intermittent symptomatic bradycardia due to AV heart block or sinus node dysfunction. The response to sensed events (first ventricular-VVI; then, atrial or dual-chamber sensing-VAT,VDD, DVI, DDD) could be inhibition or the triggering of ventricular pacing stimuli. The next important evolution was adaptive rate pacing (ARP) in the 1980s, whereby a physiologic sensor detected the need for increased paced heart rates with exercise. Physiologic responses that have been investigated and are or might be used clinically in ARP are listed in Table 1.

Keywords

Right Atrial Left Ventricular Lead Left Ventricular Pace Multicenter Automatic Defibrillator Implantation Trial Right Atrial Appendage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hayes DL, Zipes DP (2005) Cardiac pacemakers and cardioverter-defibrillators. In: Zipes DP, Libby P, Bonow RO, Braunwald E (eds) Braunwald’s heart disease, 7th edn. Elsevier Saunders, Philadelphia, pp 767–96Google Scholar
  2. 2.
    Atlee JL (1996) Arrhythmias and pacemakers. Saunders, Philadelphia, pp 205–46Google Scholar
  3. 3.
    Atlee JL, Bernstein AD (2001) Cardiac rhythm management devices. Part 1. Indications, device selection and function. Anesthesiology 95:1265–80PubMedCrossRefGoogle Scholar
  4. 4.
    Atlee JL, Bernstein AD (2001) Cardiac rhythm management devices. Part 2. Perioperative management. Anesthesiology 95:1492–1506Google Scholar
  5. 5.
    Lee TH (2005) Guidelines: cardiac pacemakers and cardioverter-defibrillators. In: Zipes DP, Libby P, Bonow RO, Braunwald E (eds) Braunwald’s heart disease, 7th edn. Elsevier Saunders, Philadelphia, pp 796–802Google Scholar
  6. 6.
    American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Cardiac Rhythm Management Devices (2005) Practice advisory for the perioperative management of patients with cardiac rhythm management devices: pacemakers and implantable cardioverter-defibrillators: a report by the American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Cardiac Rhythm Management Devices. Anesthesiology 103:186–98CrossRefGoogle Scholar
  7. 7.
    Sorajja P, Elliott PM, McKenna WJ (2000) Pacing in hypertrophic cardiomyopathy. Cardiol Clin 18:67–79PubMedCrossRefGoogle Scholar
  8. 8.
    Gregoratos G, Abrams J, Epstein AE, et al (2002) American College of Cardiology/American Heart Association Task Force on Practice Guidelines/North American Society for Pacing and Electrophysiology Committee to Update the 1998 Pacemaker Guidelines. Circulation 106:2145–61PubMedCrossRefGoogle Scholar
  9. 9.
    Atlee JL (2005) Pacemaker resynchronisation in the treatment of severe heart failure. In: Gullo A (ed) Anaesthesia, Pain, Intensive Care and Emergency Medicine (A.P.I.C.E.) 20. Springer, Milan, pp 99–112Google Scholar
  10. 10.
    Fantoni C, Auricchio A (2006) Cardiac resynchronisation therapy: do we know everything? In: Gullo A (ed) Anaesthesia, Pain, Intensive Care and Emergency Medicine (A.P.I.C.E.) 20. Springer, Milan, pp 257–66Google Scholar
  11. 11.
    Wiggers C (1926) Are ventricular conduction changes important in the dynamics of left ventricular contraction? Am J Physiol 74:12–30Google Scholar
  12. 12.
    Harrison T (1965) Some unanswered questions concerning enlargement and failure of the heart. Am Heart J 69:100–115PubMedCrossRefGoogle Scholar
  13. 13.
    Herman MV, Heinle RA, Klein MD, et al. (1967) Localized disorders in myocardial contraction. Asynergy and its role in congestive heart failure. N Engl J Med 277:222–32PubMedCrossRefGoogle Scholar
  14. 14.
    Bramlet DA, Morris KG, Coleman RE, et al (1983) Effect of rate-dependent left bundle branch block on global and regional left ventricular function. Circulation. 67:1059–65PubMedGoogle Scholar
  15. 15.
    Gillis AM (2000) Pacing to prevent atrial fibrillation. Cardiol Clin 18:25–36PubMedCrossRefGoogle Scholar
  16. 16.
    Misier AR, Beukema WP, Willems R (2003) Multisite atrial pacing for atrial fibrillation prevention: where to go from here? Card Electrophysiol Rev 7:329–32PubMedCrossRefGoogle Scholar
  17. 17.
    Saksena S, Prakash A, Ziegler P, et al (2002) Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy. J Am Coll Cardiol 40:1140–50PubMedCrossRefGoogle Scholar
  18. 18.
    Prakash A, Saksena S, Ziegler P, et al (2005) Dual site right atrial pacing can improve the hemodynamic impact of standard dual-chamber on atrial and ventricular mechanical function in patients with symptomatic atrial fibrillation: further observations from the dual site atrial pacing for prevention of atrial fibrillation trial. J Intervent Card Electrophysiol 12:177–87CrossRefGoogle Scholar
  19. 19.
    Padeletti L, Pieragnoli P, Ciapetti C, et al (2001) Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. Am Heart 142:1047–55CrossRefGoogle Scholar
  20. 20.
    Bailin SJ, Adler S, Giudici M (2001) Prevention of chronic atrial fibrillation by pacing in the region of Bachmann’s bundle: results of a multicenter randomized trial. J Cardiovasc Electrophysiol 12:912–7PubMedCrossRefGoogle Scholar
  21. 21.
    Atlee JL (2004) Decision-making in critical care: cardiac arrhythmias and related topics. In: Gullo A (ed) Anaesthesia, Pain, Intensive Care and Emergency Medicine (A.P.I.C.E.) 19. Springer, Milan, Springer-Verlag Italia Compiler/Production: page numbers≪QA16≫?Google Scholar
  22. 22.
    Olgin JE, Zipes DP (2005) Specific arrhythmias: diagnosis and treatment. In: Zipes DP, Libby P, Bonow RO, Braunwald E (eds) Braunwald’s heart disease, 7th edn. Elsevier Saunders, Philadelphia, pp 803–863Google Scholar
  23. 23.
    Pinski SL, Fahey GJ (1999) Implantable cardioverters-defibrillators. Am J Med 106:446–58PubMedCrossRefGoogle Scholar
  24. 24.
    The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators (1997) A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337:1576–83CrossRefGoogle Scholar
  25. 25.
    Moss AJ, Hall WJ, Cannom DS, et al (1996) Multicenter Automatic Defibrillator Implantation Trial Investigators: improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335:1933–40PubMedCrossRefGoogle Scholar
  26. 26.
    Moss AJ, Zareba W, Hall WJ, et al, for the Multicenter Automatic Defibrillator Implantation Trial II Investigators (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–83PubMedCrossRefGoogle Scholar
  27. 27.
    Bristow MR, Saxon LA, Boehmer J, et al (2004) Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiacresynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140–50PubMedCrossRefGoogle Scholar
  28. 28.
    Young JB, Abraham WT, Smith AL, et al (2003) Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 289:2685–94PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2007

Authors and Affiliations

  • J. L. Atlee
    • 1
  1. 1.Department of AnesthesiologyMedical College of WisconsinMilwaukeeUSA

Personalised recommendations